Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Conditions

• IGF1 Deficiency

Interventions

• DRUG: Increlex®

Sponsor

Esteve Pharmaceuticals, S.A.